SCHEMBL1315442

SCHEMBL1315442

COC(=O)c1cncc(-c2ncccn2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.57
CYP2A6 P11509 1/20 0.55
CYP11B2 P19099 5/20 0.54
CYP11B1 P15538 4/20 0.54
ALDH1A1 P00352 2/20 0.53
S1PR1 P21453 1/20 0.48
CYP19A1 P11511 1/20 0.47
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.45
NEK1 Q96PY6 3/20 0.44
SLC2A1 P11166 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ABL1 P00519 2/20 0.42
BCR P11274 1/20 0.42
SRC P12931 1/20 0.42
CDK8 P49336 1/20 0.42
PSMD14 O00487 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715051 0.86 ATM (0.69) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL31364815 0.81 MKNK2 (0.54) CYP2A6CYP11B2CYP11B1ALDH1A1HTT
SCHEMBL29771391 0.81 ALDH1A1 (0.68) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL3714867 0.81 ALDH1A1 (0.68) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL31705350 0.81 ALDH1A1 (0.68) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL31704881 0.81 ALDH1A1 (0.68) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL9008962 0.80 CYP11B1 (0.61) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL56951 0.80 ATM (0.77) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL10028685 0.80 ALDH1A1 (0.66) ATMCYP2A6CYP11B2CYP11B1ALDH1A1
SCHEMBL1319171 0.79 MKNK1 (0.53) CYP2A6ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 ATM 3088/4885CYP2A6 1303/4885CYP11B2 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.